Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · Real-Time Price · USD
3.120
-0.250 (-7.42%)
At close: Jun 22, 2026, 4:00 PM EDT
3.200
+0.080 (2.56%)
After-hours: Jun 22, 2026, 7:03 PM EDT

Co-Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1111253978302
Market Cap Growth
17.64%-57.15%-36.49%-49.83%-74.24%13.71%
Enterprise Value
5.47-0.03-2.81-16.53-3.12212.15
Last Close Price
3.125.0722.5039.9075.60267.90
PE Ratio
-----7.26
Forward PE
-----26.93
PS Ratio
16.2517.066.335.732.273.09
PB Ratio
0.760.510.460.450.682.25
P/TBV Ratio
0.570.500.820.660.902.89
P/FCF Ratio
----15.137.47
P/OCF Ratio
----11.847.35
EV/Sales Ratio
7.61-0.04-0.72-2.43-0.092.17
EV/EBITDA Ratio
-0.000.070.400.124.57
EV/EBIT Ratio
-0.000.070.390.124.61
EV/FCF Ratio
-0.000.090.70-5.25
Debt / Equity Ratio
0.070.030.020.030.000
Debt / FCF Ratio
----0.07-
Net Debt / Equity Ratio
-0.39-0.52-0.51-0.65-0.71-0.67
Net Debt / EBITDA Ratio
0.130.220.711.343.15-1.94
Net Debt / FCF Ratio
0.210.360.922.37-15.74-2.22
Asset Turnover
0.030.010.050.060.240.85
Inventory Turnover
0.430.220.731.201.502.32
Quick Ratio
1.943.424.0810.2422.378.79
Current Ratio
2.283.874.4110.8123.949.14
Return on Equity (ROE)
-264.53%-125.89%-53.81%-35.24%-11.44%36.45%
Return on Assets (ROA)
-212.67%-109.83%-50.53%-36.26%-14.40%32.00%
Return on Invested Capital (ROIC)
-401.98%-217.58%-118.06%-105.29%-38.59%85.99%
Return on Capital Employed (ROCE)
-264.57%-129.54%-54.97%-40.91%-20.24%42.93%
Earnings Yield
-----13.77%
FCF Yield
----6.61%13.38%
Buyback Yield / Dilution
-57.98%-31.55%-3.37%6.77%-5.27%-6.80%
Total Shareholder Return
-57.98%-31.55%-3.37%6.77%-5.27%-6.80%